About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Considerations for CLL
Treatment Considerations for CLL
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
O
The Tumor: Biomarker-Guided Treatment in CLL
By
ERIC 2022 - European Research Initiative on CLL - ERIC
FEATURING
Othman Al-Sawaf
By
ERIC 2022 - European Research Initiative on CLL - ERIC
FEATURING
Othman Al-Sawaf
125 views
November 8, 2022
0 Comments
Login to view comments.
Click here to Login
Treatment Considerations for CLL
08:57
Carsten Utoft Niemann
Fixed-Duration Therapy in CLL: Is It a Safer Option for Patients?
09:46
Christopher Pleyer
Venetoclax + Obinutuzumab for Previously Untreated CLL: Latest Learn…
19:42
Jacqueline Barrientos
Considerations for Sequencing Treatments in CLL
14:05
The University of Kansas Cancer Center
Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untrea…
Feat.
M. Hoffmann
33:21
Moffitt Cancer Center
MRD in CLL/SLL: Is It Ready for Prime Time?
Feat.
J. Sandoval-Sus
27:08
Tara Graff
Updates on Venetoclax in CLL
09:45
ASH 2022 Conference Coverage
ASH 2022 Treatment of CLL-Associated Autoimmune Cytopenias and Outco…
Feat.
K. Rogers
11:52
ASH 2022 Conference Coverage
ASH 2022 Real-World OS and TTNT by 1L Therapy (BTKi and BCL2i) in Pa…
Feat.
W. Archibald,
C. Wang
07:24
Kirollos Hanna
MURANO Phase 3 Trial: Enduring Undetectable MRD and Updated Outcomes…
14:12
Northwell Health
Treatment Considerations for Patients With CLL Who Are Elderly or Ha…
Feat.
J. Rhodes
14:31
Lydia Scarfò
Upcoming BTKi Therapies in CLL
11:07
SOHO 2022 Tenth Annual Meeting
SOHO 2022: BCL2i in CLL
Feat.
A. Chanan-Khan
20:55
ERIC 2022 - European Research Initiative on CLL - ERIC
The Tumor: Biomarker-Guided Treatment in CLL
Feat.
O. Al-Sawaf
21:28
ERIC 2022 - European Research Initiative on CLL - ERIC
Combined Inhibition of Signaling and Anti-Apoptotic Pathways in CLL
Feat.
P. Hillmen
06:33
Arnon Kater
Updates From a MRD Model From the MURANO Trial: CLL Clonal Growth Ra…